Atlas Trials

High Grade Serous Ovarian Cancer

22 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch High Grade Serous Ovarian Cancer

RecordFirmDate
Upifitamab Rilsodotin Maintenance in Platinum-Sensitive Recurrent Ovarian Cancer (UP-NEXT) (NCT05329545)Mersana Therapeutics2022-06-23
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan (NCT05005403)AbbVie2021-11-01
miRNAs in High Grade Serous Ovarian Cancer (NCT05146505)IRCCS Azienda Ospedaliero-Universitaria di Bologna2021-10-01
CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer (NCT05027828)Xinhua Hospital, Shanghai Jiao Tong University School of Medicine2021-09-01
NUVOLA TRIAL Open-label Multicentre Study (NCT04261465)Fondazione Policlinico Universitario Agostino Gemelli IRCCS2019-12-01
p53 Activation in Platinum-Resistant High Grade Serous Ovarian Cancer, a Study of PLD With APR-246 (NCT03268382)Aprea Therapeutics2017-07-31
A Phase I Trial of LY3143921 Hydrate in Solid Tumours (NCT03096054)Cancer Research UK2017-06-21
"Re-Stimulated" TILs And IL-2 Therapy for Platinum Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT01883297)University Health Network, Toronto2015-01-01
Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors (NCT02307240)Curis, Inc.2014-11-01
A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid Tumors (NCT01853306)AbbVie2013-03-18
Expanded Access to Veliparib (NCT03123211)AbbVie

Track High Grade Serous Ovarian Cancer automatically

Every clearance here is in the API, with alerts when new ones post.